Center-Authored Papers

Filters: Author is Gore, John L  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2011
Gulati R, Mariotto AB, Chen S, Gore JL, Etzioni R.  2011.  Long-term projections of the harm-benefit trade-off in prostate cancer screening are more favorable than previous short-term estimates.. Journal of clinical epidemiology. 64(12):1412-7. Abstract
Zeliadt SB, Hoffman RM, Etzioni R, Gore JL, Kessler LG, Lin DW.  2011.  Influence of publication of US and European prostate cancer screening trials on PSA testing practices.. Journal of the National Cancer Institute. 103(6):520-3. Abstract
2013
Xia J, Gulati R, Au M, Gore JL, Lin DW, Etzioni R.  2013.  Effects of Screening on Radical Prostatectomy Efficacy: The Prostate Cancer Intervention Versus Observation Trial.. Journal of the National Cancer Institute. Abstract
Lee FC, Harris W, Cheng HH, Shenoi J, Zhao S, Wang J, Champion T, Izard J, Gore JL, Porter M et al..  2013.  Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer.. Advances in urology. 2013:317190. Abstract
Macleod LC, Hotaling JM, Wright JL, Davenport MT, Gore JL, Harper J, White E.  2013.  Risk Factors for Renal Cell Carcinoma in the Vitamin and Lifestyle (VITAL) Study.. The Journal of urology. 190(5):1657-61. Abstract
Mossanen M, Lee F, Cheng H, Harris W, Shenoi J, Zhao S, Wang J, Champion T, Izard J, Gore JL et al..  2013.  Nonresponse to Neoadjuvant Chemotherapy for Muscle-Invasive Urothelial Cell Carcinoma of the Bladder.. Clinical genitourinary cancer. Abstract
2014
Mossanen M, Izard J, Wright JL, Harper JD, Porter MP, Daratha KB, Holt SK, Gore JL.  2014.  Identification of underserved areas for urologic cancer care.. Cancer. Abstract
Flum DR, Alfonso-Cristancho R, Devine EB, Devlin A, Farrokhi E, Tarczy-Hornoch P, Kessler L, Lavallee D, Patrick DL, Gore JL et al..  2014.  Implementation of a "real-world" learning health care system: Washington state's Comparative Effectiveness Research Translation Network (CERTAIN).. Surgery. 155(5):860-6. Abstract
Figler B, Gore JL, Holt SK, Voelzke B, Wessells H.  2014.  High Regional Variation in Urethroplasty Utilization in the United States.. The Journal of urology. Abstract
Calvert JK, Holt SK, Mossanen M, James AC, Wright JL, Porter MP, Gore JL.  2014.  Use and Outcomes of Extended Antibiotic Prophylaxis in Urologic Cancer Surgery.. The Journal of urology. Abstract
Amin MB, Lin DW, Gore JL, Srigley JR, Samaratunga H, Egevad L, Rubin M, Nacey J, Carter BH, Klotz L et al..  2014.  The Critical Role of the Pathologist in Determining Eligibility for Active Surveillance as a Management Option in Patients With Prostate Cancer: Consensus Statement With Recommendations Supported by the College of American Pathologists, International Soci. Archives of pathology & laboratory medicine. Abstract
Gulati R, Tsodikov A, Etzioni R, Hunter-Merrill RA, Gore JL, Mariotto AB, Cooperberg MR.  2014.  Expected population impacts of discontinued prostate-specific antigen screening.. Cancer. Abstract
Hsi RS, Holt SK, Gore JL, Harper JD.  2014.  Trends in Followup Imaging after Adult Pyeloplasty.. The Journal of urology. Abstract
Mossanen M, Calvert JK, Wright JL, True LD, Lin DW, Gore JL.  2014.  Readability of urologic pathology reports: The need for patient-centered approaches.. Urologic oncology. Abstract
Gulati R, Inoue LYT, Gore JL, Katcher J, Etzioni R.  2014.  Individualized estimates of overdiagnosis in screen-detected prostate cancer.. Journal of the National Cancer Institute. 106(2):djt367. Abstract
James AC, Lee FC, Izard JP, Harris WP, Cheng HH, Zhao S, Gore JL, Lin DW, Porter MP, Yu EY et al..  2014.  Role of Maximal Endoscopic Resection Before Cystectomy for Invasive Urothelial Bladder Cancer.. Clinical genitourinary cancer. Abstract
James AC, Holt SK, Wright JL, Porter MP, Gore JL.  2014.  Burden and timing of venothrombolic events in patients younger than 65 years undergoing radical cystectomy for bladder cancer.. Urologic oncology. Abstract
258
Amin MB, Lin DW, Gore JL, Srigley JR, Samaratunga H, Egevad L, Rubin M, Nacey J, Carter BH, Klotz L et al..  2014.  The Critical Role of the Pathologist in Determining Eligibility for Active Surveillance as a Management Option in Patients With Prostate Cancer: Consensus Statement With Recommendations Supported by the College of American Pathologists, International Soci. Archives of pathology & laboratory medicine. Abstract
Adult
Zeliadt SB, Hoffman RM, Etzioni R, Gore JL, Kessler LG, Lin DW.  2011.  Influence of publication of US and European prostate cancer screening trials on PSA testing practices.. Journal of the National Cancer Institute. 103(6):520-3. Abstract
Aged
Zeliadt SB, Hoffman RM, Etzioni R, Gore JL, Kessler LG, Lin DW.  2011.  Influence of publication of US and European prostate cancer screening trials on PSA testing practices.. Journal of the National Cancer Institute. 103(6):520-3. Abstract
August 2014
Figler B, Gore JL, Holt SK, Voelzke B, Wessells H.  2014.  High Regional Variation in Urethroplasty Utilization in the United States.. The Journal of urology. Abstract
Gulati R, Tsodikov A, Etzioni R, Hunter-Merrill RA, Gore JL, Mariotto AB, Cooperberg MR.  2014.  Expected population impacts of discontinued prostate-specific antigen screening.. Cancer. Abstract
Amin MB, Lin DW, Gore JL, Srigley JR, Samaratunga H, Egevad L, Rubin M, Nacey J, Carter BH, Klotz L et al..  2014.  The Critical Role of the Pathologist in Determining Eligibility for Active Surveillance as a Management Option in Patients With Prostate Cancer: Consensus Statement With Recommendations Supported by the College of American Pathologists, International Soci. Archives of pathology & laboratory medicine. Abstract
Center-Authored Paper
Macleod LC, Hotaling JM, Wright JL, Davenport MT, Gore JL, Harper J, White E.  2013.  Risk Factors for Renal Cell Carcinoma in the Vitamin and Lifestyle (VITAL) Study.. The Journal of urology. 190(5):1657-61. Abstract
Clinical Research Division
Mossanen M, Lee F, Cheng H, Harris W, Shenoi J, Zhao S, Wang J, Champion T, Izard J, Gore JL et al..  2013.  Nonresponse to Neoadjuvant Chemotherapy for Muscle-Invasive Urothelial Cell Carcinoma of the Bladder.. Clinical genitourinary cancer. Abstract